Shanghai Haikang Pharmaceutical Tech.& Deve. Co., Ltd., which
consists of two business segments research and development (R&D) of biological
drug and plant extracts, is located in State Biotech Pharmaceutical industrial
base, Shanghai International Medical Zone. The company has strong R&D background
and has introduced several professors from Cancer Institute Chinese Academy of
Medical Sciences, which have laid a solid foundation for her high-growth and
core competitiveness. In the aspect of biological new drug R&D, enterprise
exists several monoclonal antibodies as key development projects, all that with
independent intellectual property rights are reported in clinical stage or
preclinical stage respectively.